IP Library Granted Patent US 6,858,584
Granted Patent B2
US 6,858,584 · App. 09/846,893 · Granted Feb 22, 2005

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,584
App. No.
09/846,893
Granted
Feb 22, 2005
Kind
B2
Abstract

Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Claims (17)

1. A pharmaceutical composition comprising:

(a) a cyclodextrin; and

(b) a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof.

2. The pharmaceutical composition of claim 1 which further comprises water.

3. The pharmaceutical composition of claim 1 which is a powder.

4. The pharmaceutical composition of claim 1 which is a lyophilized powder.

5. A pharmaceutical composition comprising:

(a) an aqueous cyclodextrin carrier and

(b) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof.

6. The pharmaceutical composition of claim 5 , wherein the pharmaceutical composition comprises:

(a) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof;

(b) 1 to 40 weight percent of a cyclodextrin; and

(c) 60 to 99 weight percent of water based on 100 weight percent of the composition.

7. The pharmaceutical composition of claim 5 , wherein the cyclodextrin is hydroxypropyl-β-cyclodextrin or sulfobutyl ether β-cyclodextrin.

8. The pharmaceutical composition of claim 7 , wherein the cyclodextrin is hydroxypropyl-β-cyclodextrin.

9. The pharmaceutical composition of claim 6 , wherein the cyclodextrin comprises about 5 to 35 weight percent of the composition.

10. The pharmaceutical composition of claim 9 , wherein the cyclodextrin comprises about 10 to 30 weight percent of the composition.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: JUDICE, J. KEVIN; SHAW, JENG-PYNG; MU, YONGQI; CONNER, MICHAEL W.
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: JUDICE, J. KEVIN
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2009
From: PACE, JOHN L.
To: ADVANCED MEDICINE, INC.
Reel/Frame 023379/0493 →
MERGER Recorded Oct 13, 2009
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 023364/0442 →
MERGER Recorded Jun 14, 2002
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 013005/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2002
From: PACE, JOHN L.
To: ADVANCED MEDICINE, INC.
Reel/Frame 012652/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2001
From: JUDICE, J. KEVIN; SHAW, JENG-PYNG; MU, YONGQI; CONNER, MICHAEL W.
To: ADVANCED MEDICINE, INC.
Reel/Frame 012207/0150 →